Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$1.84
+7.60%
Mkt Cap $8.85M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
Implied Upside
+552.2%
Consensus $12.00 vs current $1.84
NASDAQ·Healthcare·Biotechnology
$1.84
+7.60%
Mkt Cap $8.85M
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
+552.2%
Consensus $12.00 vs current $1.84